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Abstract 
Chemical Exchange Saturation Transfer (CEST) Magnetic Resonance Imaging (MRI) is a molecular 
imaging methodology capable of mapping brain metabolites with relatively high spatial resolution. 
Specificity is the main goal of such experiments; yet CEST is confounded by spectral overlap between 
different molecular species. Here, we overcome this major limitation using a general framework 
termed overlap-resolved CEST (orCEST) – a kind of spectrally-edited experiment restoring specificity. 
First, we present evidence revealing that CEST experiments targeting the central nervous system’s 
primary excitatory neurotransmitter, Glutamate (GluCEST) – is significantly contaminated by gamma-
aminobutyric acid (GABA) – the primary inhibitory neurotransmitter in the CNS. Then, we harness 
the novel orCEST methodology to separate Glutamate and – for the first time – GABA signals, thus 
delivering the desired specificity. In-vivo orCEST experiments resolved the rat brain’s primary 
neurotransmitters and revealed changes in Glutamate and GABA levels upon water deprivation in 
thirst-related areas. orCEST’s features bode well for many applications in neuroscience and 
biomedicine. 
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Introduction 
Molecular Imaging aims at spatially resolving signals originated from specific molecules with high 
precision and, preferably, noninvasively. Chemical Exchange Saturation Transfer (CEST) is a Magnetic 
Resonance Imaging (MRI) modality offering Molecular Imaging capabilities for contrasting 
endogenous metabolites: rather than using a genetically-labelled fluorophore or radioactive tracer, 
CEST MRI simply harnesses saturation (Fig. 1A) (or, less commonly, inversion or phase) transfer of 
signals originating from particular molecular species to the ubiquitous water signals1,2,which can then 
be imaged at a high spatial resolution and completely noninvasively. For example, CEST MRI has been 
used to detail Glycogen variations in the liver3; report on glucose uptake and metabolism4, detect 
myoinositol differences in grey/white matter5; and delineate creatine in skeletal muscle6. Also, CEST 
MRI was reported to be capable of mapping pH changes in the brain, and was used in many other 
applications7–9.  
Despite that specificity is the main goal of Molecular Imaging in general and CEST experiments 
in particular, CEST’s specificity can suffer from spectral overlap of different chemical moieties (Fig. 
1B). That is, two different molecules may have overlapping spectra which, upon saturation, provide 
partial contributions from both resonances rather than the desired one. In addition resonances from 
the same proton can have different offsets due to pH10. A striking example for spectral overlap 
between different molecules involves exchangeable protons of Glutamate (Glu) and Gamma-
aminobutyric acid (GABA), the Central Nervous System’s primary excitatory and inhibitory 
neurotransmitters, respectively11. Glutamate and GABA’s roles in neural activity are paramount not 
only in normal brain function, but also in many brain disorders, including, among others, dementia, 
depression, epilepsy and schizophrenia12–16. Changes in Glu and GABA concentrations have been 
spectroscopically detected in a single voxel in disease14, development17, and plasticity18, both in 
humans19  and in rodents13. CEST MRI targeting Glutamate signals (termed GluCEST) has been 
recently reported10. However, Glutamate and GABA have very similar chemical compositions, and 
both exhibit CEST effects for their respective amine moieties. Contamination from other metabolites, 
including GABA, has been largely discounted in previous gluCEST literature10,20–22, discarded as 
minimal due to (assumingly) sufficient spectral separation between the metabolite resonances; low 
competing CEST effect due to specific metabolite exchange rates; or even simply due to GABA’s lower 
relative concentration in the brain23. Still, this ambiguity can have significant consequences in the 
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interpretation of gluCEST data, due to the opposing neurotransmission effects. GABA CEST24,25 has 
rarely been claimed compared to its Glutamate counterpart, likely due to the same overlap issue. 
Here, we propose a general methodology capable of resolving spectral overlaps in CEST, termed 
overlap-resolved CEST (orCEST), which serves to significantly enhance CEST specificity. We 
investigate the extent of contamination between Glu and GABA in conventional gluCEST, and then 
demonstrate that, using the novel orCEST approach, both metabolites can be fully resolved and 
mapped separately. The first in-vivo orCEST experiments resolving Glu and GABA in-vivo are 
reported; changes in Glu and GABA levels, likely reflecting Glutamatergic and GABAergic 
mechanisms, are observed upon water-deprivation in the rat, in specific brain areas regulating 
thirst26–32. Potential implications for future studies are discussed.  
  
5 
 
Results 
orCEST principles and optimisiation 
Conventional CEST irradiation is typically performed at a particular frequency, 𝜔𝑝𝑒𝑎𝑘  (Figure 1), 
aiming to maximize the contrast; however, contaminations from all the underlying signals are then 
also present.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. CEST and orCEST mechanism of action. (A) Irradiation of protons using a frequency-selective saturation pulse: 
Chemical exchange transfers magnetization to bulk water, resulting in indirect saturation of the bulk water that is 
dependent on the frequency of irradiation. (B) orCEST method for resolving metabolite overlap, detailing the necessary 
steps and conditions to increase specificity in targeting a given metabolite i by reducing metabolite’s j contribution to the 
total CESTasym signal (C) CEST asymmetry curves for Glutamate and GABA at pH 7.2, with vertical grey lines depicting 
the acquisition frequencies necessary for orCEST calculation and blue and red horizontal lines displaying frequencies 
where ωa = ωb for Glutamate and GABA, respectively. (D) Comparison between Conventional CEST and orCEST Glutamate 
(10 mM) and GABA (2 mM) at pH 7.2, showing increased specificity in orCEST. 
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As explained above, the main goal of orCEST is to enhance the specificity of CEST experiments. The 
idea behind orCEST is in fact very simple, and is an analogue of spectral editing typically used in 
NMR33, but applied to the CEST asymmetry (CESTasym) spectra (Fig. 1B). If two metabolite signals 
partially overlap, their CESTasym spectra will display partially shifted peaks (Fig. 1B); if the z-spectra 
are a-priori known (i.e., measured in phantoms for example), symmetric points can be chosen around 
the peak and subtracted. Upon such subtraction, the contamination arising from the complementary 
molecules is effectively subtracted and cancelled out. In the orCEST experiment, maps are generated 
by subtracting images saturated at at −𝜔𝑝𝑒𝑎𝑘   and +𝜔𝑝𝑒𝑎𝑘 , normalized to M0. Thus, in orCEST, a 
total of four images are required, each acquired at different saturation frequencies (as well as 
another M0 image). In the case of Glu and GABA, the resonances to be saturated were chosen as 
±1.15/±0.35 p.p.m., and ±0.75/±2.15 p.p.m., for resolving Glutamate and GABA, respectively (Fig. 1c). 
For optimisation purposes, a range of saturation parameters were investigated, varying in number, 
length, power, duration, and separation of saturation pulses. From this initial screening, a subset of 
parameters suitable for orCEST saturation was chosen, and consisted of a train of 22 Gaussian pulses, 
182 ms in duration and 15 Hz in width, and applied with 10 µT amplitudes and an inter-pulse delay 
of 5 ms. For other experimental details, the reader is referred to the Methods section.  
 
orCEST enhances specificity for Glu and GABA 
To investigate how orCEST could enhance the spectral specificity, we first show how different 
metabolites contribute to conventional CEST contrast (particularly, to gluCEST). Fig. 2A shows the 
experimental setup, incorporating different metabolites at physiological concentration (detailed in 
caption); Figure 2B shows the corresponding CESTasym curves for these metabolites, while Fig. 2C 
displays the ensuing (conventional) gluCEST contrast and its orCEST counterpart. Although Glutamate 
presents the strongest CEST signals as evident both by the intensity of the CESTasym curves as well as 
the relative amplitude in the quantified map, it is clear that other molecules cannot be ignored and 
that gluCEST contrast contains significant contributions from other molecules. Fig. 2D quantifies this 
effect, showing that around half of the signal in conventional gluCEST actually comes from other 
metabolites (Glu 20%, NAA 3%, GABA 7%, MI 1%, Cr 4%, Gln 7%), and, more importantly, with a 
considerable amount emerging from GABA – arguably the least desired contribution due to its 
opposing action to Glu in neurotransmission. By contrast, when the orCEST methodology is used, the 
specificity is significantly enhanced and the contrast reflects mainly Glutamate, containing only 
smaller residual signals from other molecules (Glu 16%, NAA 0.5%, GABA 2%, MI 3%, Cr 2%, Gln 1%). 
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Notice that other molecules are nearly in the noise level due to orCEST subtraction. Most importantly, 
GABA’s contribution to Glutamate orCEST is now greatly reduced.   
 
 
 
 
 
 
 
 
 
 
Figure 2. Brain Metabolite contamination in CEST/orCEST. (A) Raw data acquired for characterisation of possible 
metabolic contamination in orCEST. Brain metabolites at their physiological concentrations, Creatine (Cr, 4 mM), 
myoinositol (MI, 5 mM), N-acetyle aspartate (NAA, 8 mM), glutamine (Gln, 3 mM), Glu (10 mM) and GABA (2 mM).  Image 
displays an acquisition without any frequency selective saturation pulse, showing no discernible difference between 
metabolites. (B) CEST asymmetry profiles of the aforementioned metabolites showing significant overlap between them. 
(C)(E) Conventional CEST and orCEST maps for Glutamate and GABA, respectively, showing improved specificity in both 
cases, with greatly reduced contamination from unwanted sources. (D)(F) Comparison between Conventional CEST and 
orCEST showing the massive reduction in unwanted contribution from other brain metabolites while Glutamate and 
GABA, respectively, maintain their CEST contrast after their respective orCEST subtraction. 
 
As mentioned earlier, conventional gabaCEST contrast has insofar not been widely 
reported24,25 as its glutamate counterpart. Fig. 2E displays the conventional gabaCEST contrast and 
its orCEST counterpart, showing the likely reason: conventional gabaCEST is severely contaminated 
with Glutamate and other molecules and in fact, the Glutamate signal is stronger than GABA’s (Glu 
16%, NAA 2%, GABA 15%, MI 2%, Cr 8%, Gln 9%). Indeed, GABA only contributes to about a quarter 
of total signal in a conventional gabaCEST acquisition (Fig. 2F), suggesting that indeed it would be 
difficult to ascribe specificity to gabaCEST under these conditions. When orCEST was attempted to 
resolve GABA, specificity was greatly enhanced in orCEST contrast. Residual contributions from 
Glutamate, Glutamine and Creatine are minor, with a special interest for the reduction on Glutamate 
contribution (Glu 2.5%, NAA 0.5%, GABA 14%, MI 1.5%, Cr 1.5%, Gln 2.5%). 
It is worth noting that the subtraction inherent to orCEST incurs a small loss in sensitivity, 
which was found to be around 10-20%.  
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Glutamate and GABA CEST - pH effects  
In the CNS, Glutamate and GABA are compartmentalized into at least two distinct main pools: extra-
vesicular (mainly in the synaptic cleft and the cytosol) and intra-vesicular (within synaptic vesicles). 
Interestingly, each of these spaces is characterized by a very different pH: ~7.2 and ~5.5 for synaptic 
and intravesicular, respectively34. Conventional gluCEST is thought to originate mainly from pH 5.510; 
however, given the strong effects shown above, it could be suspected that different pH environments 
may significantly contribute to CEST contrast.   
Fig. 3A shows the setup used to test different pH effects on CEST and orCEST signals, 
comprising GABA and Glutamate tubes at pH 5.5 and 7.2, respectively, at physiological 
concentrations23. The corresponding CEST asymmetry curves (Fig. 3B) show that both metabolites 
behave very differently at different pH.   
 
 
 
 
 
 
 
 
 
Figure 3. Glutamate and GABA CEST/orCEST pH dependency. (A) Raw data acquired for characterisation of orCEST, 
Glutamate (10 mM) and GABA (2 mM) at pH 5.5 and 7.2.  In the acquisition without any frequency selective saturation 
pulse, no discernible difference between Glutamate and GABA can be observed at any given pH (B) CEST asymmetry 
profiles of both Glutamate and GABA, at pH 5.5 and 7.2, showing a clear overlap of the two metabolites. (C)(E) 
Conventional CEST and orCEST maps for Glutamate and GABA, respectively, showing improved specificity in both cases, 
with greatly reduced contamination from unwanted sources. (D)(F) Comparison between Conventional CEST and orCEST 
showing improved specificity with pH. Bright red/blue represents pH 7.2, while pale red/blue represents pH 5.5, for 
Glutamate and GABA, respectively. 
 
The map corresponding to conventional gluCEST, which primarily targets Glutamate at pH 5.5 
is shown in Fig. 3C, as is Glutamate orCEST. Since three tubes are clearly seen in the contrast, it 
becomes clear that not only does GABA contribute to gluCEST, but that glutamate at pH 7.2, which 
has a potentially different biological role than that of the intended contrast at pH 5.5, contributes 
significantly to the signal (Glu pH7.2 15%, Glu pH5.5 26%, GABA pH7.2 4%, GABA pH5.5 12%). When 
orCEST was applied to target Glutamate, it could clearly distinguish the population of interest: GABA 
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tubes are not visible/quantifiable. However, it is worth noting that pH 7.2 or 5.5 both contribute to 
the orCEST contrast (Glu pH7.2 11%, Glu pH5.5 9%, GABA pH7.2 1%, GABA pH5.5 ~0%). 
Fig. 3E shows conventional gabaCEST contrast and its orCEST counterpart, for these two pH 
populations. Conventional gabaCEST once again exhibits higher contrast for Glutamate than GABA 
itself (Glu pH7.2 17%, Glu pH5.5 23%, GABA pH7.2 8%, GABA pH5.5 5%). When GABA was targeted 
with orCEST, it again is able to distinguish between the populations, as evident from the lack of signal 
in the Glutamate tubes. Furthermore, we were able to isolate the GABA residing at pH 7.2, with very 
little GABA at pH 5.5 residuals (Glu pH7.2 2.5%, Glu pH5.5 2.5%, GABA pH7.2 8%, GABA pH5.5 1%), 
as seen in Fig. 3F. 
 
In vivo orCEST. Following orCEST validation in-vitro, the first experiments in-vivo were performed in 
rats. Figure 4A shows the raw data from such acquisitions at three different saturation frequencies 
(0,-3 and +3 p.p.m.), showing the effects of direct saturation and asymmetry in saturation. In-vivo 
orCEST maps of Glutamate and GABA (pH 7.2) are shown in Fig. 4B and C, respectively. 
Lower levels of Glutamate and GABA were found in areas rich in white matter. Glutamate 
levels were ~4 times higher than GABA, as expected for standard physiological levels in the 
brain13,19,35,36.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Raw CEST data and orCEST maps of 
control rat brains (A) Single animal raw data 
(masked) showing the effects of three 
different saturation frequencies (0, -3, and 
+3 p.p.m. from left to right), illustrating the 
effects of direct saturation and asymmetry in 
saturation effects. SNR ~25 with saturation 
at +3 p.p.m. (B,C) orCEST contrast for 
Glutamate and GABA in the rat brain, 
acquired across an axial plane at bregma 
0.7/-0.9 /-1.46mm.  
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Application of orCEST in water deprivation. Thirst regulation involves several brain regions 
and Glutamatergic/GABAergic mechanisms. Imaging those noninvasively could make a big impact on 
understanding brain circuitry in-vivo. Here, orCEST was used to investigate changes in these 
neurotransmitters in the rat brain in vivo upon water deprivation. 
A general decreasing trend is shown for both GABA and Glutamate orCEST in a ROI 
encompassing the whole brain (see Fig. 5A). However, specific structures, such as the Hypothalamus 
(Fig.  5B), Corpus Callosum (Fig. 5C) and Caudate Putamen (Fig.5D), exhibited a different behaviour 
upon water deprivation, with Glutamate evidencing a significant decrease for the 24H group, 
followed by an increase in the for the 36H group. This suggests that specific structures may have 
some sort of compensatory mechanism for Glutamate and GABA that is implicated in thirst 
regulation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. orCEST variations upon water deprivation in rats at 9.4T (A) Analysis on the average of all structures shows a 
significant downwards trend in both Glutamate and GABA between Control, 24H and 36H groups. This is the case for 
most brain structures. (B,C,D) Specific structures, such as the Hypothalamus (bregma -1,46mm), Corpus Callosum 
(bregma -0.9mm) and Caudate Putamen (bregma -0.9mm), exhibit a different behaviour upon water deprivation.   
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Discussion 
CEST experiments in general, and Glu/GABA-CEST in particular, strive to enhance the specificity of 
MRI experiments. However, CEST-based contrasts typically saturate at the resonance peaks to 
maximize contrast; in such settings, the specificity of the methodology may be significantly reduced, 
as here shown, due to spectral overlap from other metabolites. Many parameters can be expected 
to affect the degree of contamination by unwanted metabolites, including the respective frequencies 
and magnetic fields, as well as exchange rates, pH, and temperature. Still, it seems that, especially 
for Glutamate and GABA, conditions are unfavourable for conventional CEST experiments.  
 We presented the orCEST methodology, which aims at enhancing the specificity, even if at 
the expense of scan time (orCEST requires double the images, but if the resonances are judiciously 
chosen, orCEST will also report on double the metabolites) and some small decrease in sensitivity 
due to saturation off-peak. However, we have shown that orCEST provides significantly enhanced 
specificity which potentially resolves the molecular overlap and can partially resolve pH-related 
overlap, thereby providing exciting vistas for future mapping of specific (sub)cellular environments 
in-vivo.  
Our findings are important in the context of interpretation of CEST contrasts in general, and 
GluCEST in particular. Indeed, GluCEST contrasts in different conditions, such as stroke models, 
epilepsy, psychosis or Huntington’s disease10,21,22,37 have shown markedly different contrasts. Given 
the GABA contributions to GluCEST here shown, one must consider whether GABAergic contributions 
could have played an important role in these contrasts.  
As a general method for measuring long term Glutamate/GABA changes in the brain, orCEST 
may prove to be quite a valuable tool due to its increased specificity, especially for GABA 
measurements in vivo. GABA also plays a very important role in disease38–40, and studying its variation 
may become a possible with orCEST. Epileptic drugs for example, often rely on the inhibition of 
release/reuptake of GABA in gabaergic neurons41, and less so on Glutamatergic processes. orCEST 
could provide specificity and thereby facilitate direct imaging of such effects. Indeed, in our water 
deprivation model, with the exception of three major structures, Hypothalamus (bregma -1,46mm), 
Corpus Callosum (bregma -0.9mm), and Caudate Putamen (bregma -0.9mm) (supplementary Fig. 1), 
most brain regions show a consistent decrease in both Glutamate and GABA orCEST. Previous studies 
on rat models have reported an increase in hypothalamic Glutamate, upon acute dehydration over a 
48h period42, and for both Glutamate and GABA upon 7 to 10 days of chronic dehydration (2% NaCl 
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in water)43, evidenced by an increase in the frequency of spontaneous excitatory and inhibitory 
postsynaptic currents that can perhaps be attributed to elevated levels of both neurotransmitters. 
Because these experiments do not include data on short-term water deprivation (24 hours), no 
comparison can be made on the Glutamate/GABA decrease seen in our data for the first 24 hours 
post water deprivation. A similar variation for Glutamate and GABA was found in our data for the 
Caudate Putamen, which has mostly been associated with the initiation and control of movement 
related to water consumption, rather than more specifically to the control of thirst44. 
There are, of course, drawbacks associated with orCEST. First, twice the number of images need 
to be acquired, which can present practical limitations. Secondly, orCEST (and the majority of the 
CEST applications for that matter) relies on a stable pH, which should be taken into account in models 
where pH changes are expected. Changes in pH are responsible for the phenomenon of intermediate-
to-fast-exchange (k ≥ Δω)-mediated chemical shift averaging2, which ultimately results in a frequency 
shift in the CEST asymmetry curve. While this effect has been taken advantage of in the past8,9,45–47, 
considering the reliance of orCEST on the subtraction of specific frequencies, it is certainly important 
to consider it in order to choose a suitable model to investigate. Other factors, such as temperature 
and concentration can also affect the exchangeable resonances, albeit to smaller consequence. 
Finally, just as in CEST, asymmetric magnetization transfer (MT) effects may contaminate orCEST 
signals because of potential magnetization exchange between water molecules bound to larger 
macromolecules in solid or semisolid phases and free water.  
In conclusion, orCEST significantly enhances the specificity in CEST experiments. Our application 
for Glu and GABA opens an array of possibilities for studies on the inhibitory gabaergic system, while 
also increasing the specificity for Glutamate imaging using MRI, in a non-invasive manner. These 
augur well for future molecular imaging studies.  
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Materials and Methods 
 
Phantoms  
Metabolite solutions were prepared using 1xPBS (pH ~ 7.2) as the solvent and their pH was 
controlled by titration with 0.1 M HCl or 0.1 M NaOH. The pH was measured using a Sartorius docu-
pH Meter [Sartorius AG, Goettingen, Germany] accurate to 0.1 pH units.  
These samples were added to small test tubes (3 mm diameter), and immersed inside a larger 
(10 mm) NMR tube filled with Fluorinert [Sigma-Aldrich Chemie Gmbh, Munich, Germany], to match 
susceptibility. To assess pH dependency and variation, two Glutamate solutions with pH 7.2 and pH 
5.5, and two GABA solutions with pH 7.2 and pH 5.5, were prepared. The pH values of 7.2 and 5.5 
were chosen in accordance to the intra and extra vesicular environment in which these metabolites 
can be found34. To evaluate the contribution of other major brain metabolites in orCEST signals, 
solutions of the following metabolites in their typical range of physiological concentrations23 were 
prepared: creatine (Cr, 4 mM), myoinositol (MI, 5 mM), N-acetyle aspartate (NAA, 8 mM), glutamine 
(Gln, 3 mM), Glu (10 mM) and GABA (2 mM). All samples were adjusted to pH 7.2 just prior to imaging.  
In vitro experiments were performed on a Bruker Ascend Aeon 16.4 T vertical scanner 
(Bruker, Karlsruhe, Germany), on a micro5 probe equipped with a 10 mm coil, and a gradient system 
capable of producing 3000 mT/m in all directions, or, for the metabolic contamination phantom 
experiment, on a micro2.5 probe equipped with a 25 mm coil and a gradient system capable of 
producing up to 1500mT/m in all directions.  
Phantom experiments were performed at 37°C, using a modified Half-Fourier Acquisition 
Single-shot Turbo spin Echo imaging (HASTE)48 sequence preceded by a CEST module. Imaging 
parameters were as follows, TR/TE = 15000 / 15 ms, FOV = 9x9 mm, slice thickness = 3 mm, Matrix 
size = 56x56, number of π-pulses = 33, partial Fourier factor = 1.8, number of averages = 2, with a 
total scan time per run of 30 s. All experiments were acquired in a fully relaxed state (TR > 5T1). For 
optimisation purposes, a range of saturation parameters were investigated, varying in number, 
length, power, duration, and separation of saturation pulses. From this initial screening, a subset of 
parameters suitable for orCEST imaging were chosen, and consisted of a train of 22 Gaussian pulses, 
182 ms in duration and 15 Hz in width, and applied with 10 µT amplitudes and an inter-pulse delay 
of 5 ms.  Raw CEST acquisition in phantoms consisted of an array of varying saturation offset 
frequencies ranging from -3.25 to +3.25 p.p.m. (-5 to +5 p.p.m. to assess pH dependency), varied in 
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steps of 0.02 p.p.m. (15Hz at 16.4T). An M0 image (identical sequence but with zero power on the 
saturation pulses) for normalization was also acquired.    
 
In Vivo 
Long-Evans male rats (6-9 weeks old and weighing 220-320g), housed 2 per cage and allowed ad 
libitum access to food and water before the study started were randomly split into three groups, 
Control (n=16), 24H Water Deprived (24H, n=16), and 36H Water Deprived (36H, n=16). The first 
group was allowed ad libitum access to food and water, while the second and third were water 
deprived for 24h and 36h, respectively. In the beginning of water deprivation, healthy animals were 
weighted and the water bottles on the cages were made unavailable. All animals were monitored 
every 12 hours and the continuation of water restriction was decided according to welfare and health 
of individuals. 
Animals were anesthetized with 5% isofluorane for induction, and ~2.5% for maintenance 
delivered through a nosecone and carried by 95% Oxygen (medical air). Once anesthetized, the 
animals were placed in a dedicated animal bed and inserted vertically to the MRI scanner. Breathing 
rate and temperature were monitored throughout the experiment using a SA Instruments Model 
1030 Monitoring & Gating system (SA Instruments Inc, NY, USA) interfaced with the scanner.  
In vivo experiments were conducted on a Bruker BioSpec 9.4T equipped with a Rat cryoprobe 
and a gradient system capable of producing up to 660 mT/m in all directions. All acquisitions were 
performed with the animal kept at a stable temperature of 37°C, using a modified Half-Fourier 
Acquisition Single-shot Turbo spin Echo imaging (HASTE)48 sequence preceded by a CEST module. 
Imaging parameters were: TR/TE = 10000/14.7ms, FOV = 24x24mm, slice thickness = 1.25mm, Matrix 
size = 80x80, number of refocusing pulses=44, partial Fourier factor=1.8, number of averages = 10, 
with a total scan time per run of 1m40s. All experiments were acquired in a fully relaxed state 
(TR>5T1). Saturation consisted of 22 Gaussian pulses, 182ms/15Hz, 10µT, with an interpulse delay of 
5ms. A total of three slices were acquired across an axial plane at bregma 0.7/-0.9 /-1.46mm. B0 and 
B1 profiles were optimized per slice prior to each acquisition. Besides the CEST data acquired at 
multiple , data for B1 and B0 correction was also acquired. One-way ANOVA corrected for multiple 
comparisons was used to analyse the acquired data.  
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orCEST Quantification 
CEST contrast is determined through the collection of a Z-spectrum, a plot of the normalized z 
magnetization of water, as described by 
[Eq.1] 
𝑀𝑠𝑎𝑡(𝜔)
𝑀0
⁄  
 
where Msat(ω) and M0 represents magnetization saturated at frequency ω and unsaturated 
magnetization, respectively. 
For conventional CEST applications, each metabolite can be characterised by its own CEST 
asymmetry spectrum,  
[Eq.2] 
𝐶𝐸𝑆𝑇𝑎𝑠𝑦𝑚,𝑖 =
𝑀𝑠𝑎𝑡(−ω) − 𝑀𝑠𝑎𝑡(ω)
𝑀0
 ×  100 
 
where i represents the ith metabolite. Such CESTasym spectra tend to exhibit local maxima; if the peak 
arises from a single metabolite, its saturation at 𝜔𝑝𝑒𝑎𝑘,𝑖  should provide specificity to metabolite i. 
However, if another metabolite j has overlapping CESTasym signals, saturation at 𝜔𝑝𝑒𝑎𝑘,𝑖 would 
inherently lead to contamination from metabolite j.  
One potential solution for this contamination, is to use a kind of “spectral editing”: that is, 
find a way to subtract out one of the metabolite signals. Due to the peaked shape of the spectra, 
there should exist at least two frequencies for which CESTasym intensities are identical 
[Eq. 3] 
𝐶𝐸𝑆𝑇𝑎𝑠𝑦𝑚,𝑖(𝜔𝑎) = 𝐶𝐸𝑆𝑇𝑎𝑠𝑦𝑚,𝑖(𝜔𝑏) 
 
where 𝜔𝑎 ≠ 𝜔𝑏  (Fig. 1B). Similarly, for metabolite 𝑗 ≠ 𝑖 with a partially overlapping peaked CESTasym 
spectrum, one can find frequencies 𝜔𝑐,𝑑  such that  𝜔𝑐 ≠ 𝜔𝑑  (≠ 𝜔𝑎 ≠ 𝜔𝑏) for which 
[Eq. 4] 
𝐶𝐸𝑆𝑇𝑎𝑠𝑦𝑚,𝑖(𝜔𝑐) = 𝐶𝐸𝑆𝑇𝑎𝑠𝑦𝑚,𝑖(𝜔𝑑) 
 
Each frequency pair can thus serve as subtraction points, for which signals from one specific 
metabolite will be nulled; that is, one can null the effects of metabolite i while preserving contrast 
16 
 
from metabolite j (Fig. 1B). The task for such overlap-resolved CEST (orCEST) spectra is then to select 
frequency pairs such that contribution from unwanted sources is minimized, while preserving the 
maximum possible CEST effect for the desired metabolite. For peak signals i,j and nulling frequencies 
𝜔𝑐 and 𝜔𝑑  nulling signal j and 𝜔𝑎 and 𝜔𝑏  nulling signal i (Fig. 1B): 
[Eq. 5] 
𝑜𝑟𝐶𝐸𝑆𝑇𝑖 =  𝐶𝐸𝑆𝑇𝑎𝑠𝑦𝑚(𝜔𝑐) − 𝐶𝐸𝑆𝑇𝑎𝑠𝑦𝑚(𝜔𝑑) 
𝑜𝑟𝐶𝐸𝑆𝑇𝑗 =  𝐶𝐸𝑆𝑇𝑎𝑠𝑦𝑚(𝜔𝑎) − 𝐶𝐸𝑆𝑇𝑎𝑠𝑦𝑚(𝜔𝑏) 
 
Metabolites i and j have thus been resolved with considerably more specificity.  
  
Data Analysis 
Image processing and data analysis were done in MATLAB r2015b® (The Mathworks, Nattick, MA, 
USA), using custom-written code. Intermediate frequency CEST-weighted images were interpolated 
with spline fitting to obtain the signal intensity S at the desired offsets ωdesired, 
[Eq.6] 
𝑆𝑖𝑛𝑡𝑒𝑟𝑝𝑜𝑙𝑎𝑡𝑒𝑑 = 𝑠𝑝𝑙𝑖𝑛𝑒[ω𝑒𝑥𝑝, S𝑒𝑥𝑝(𝑥, 𝑦, 𝜔𝑒𝑥𝑝), 𝜔𝑑𝑒𝑠𝑖𝑟𝑒𝑑 (𝑥, 𝑦)] 
 
To correct for spatial B0 field variations, WASSR correction49 was used. The irradiated frequencies are 
adjusted by 
[Eq.7] 
𝜔𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑(𝑥, 𝑦) =  𝜔𝑒𝑥𝑝(𝑥, 𝑦) −  ẟω0(𝑥, 𝑦) 
 
All in vivo data were denoised using Veraart’s method of Marchenko-Pastur distribution 
removal in PCA of redundant datasets50, and then corrected for Gibbs ringing using the Gibbs 
unringing algorithm presented by Kellner et al.51, prior to further analysis. ROIs for in vivo orCEST 
data were drawn manually with the help of a rat brain atlas52, and data was tested for normality using 
One-Sample Kolmogorov-Smirnov test. Grubbs’ test for outliers was applied and new points were 
interpolated if needed. Equivalent ROIs from different animals within the same group were clustered 
and a one-way ANOVA was applied on both Control, 24H and 36H groups, with a Post Hoc multiple 
comparisons test (Bonferroni correction). Plots were generated from this analysis pipeline. 
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Figure Captions 
Fig. 1 CEST and orCEST mechanism of action (A) Irradiation of protons using a frequency-selective 
saturation pulse: Chemical exchange transfers magnetization to bulk water, resulting in indirect 
saturation of the bulk water that is dependent on the frequency of irradiation. (B) orCEST method 
for resolving metabolite overlap, detailing the necessary steps and conditions to increase specificity 
in targeting a given metabolite i by reducing metabolite’s j contribution to the total CESTasym signal 
(C) CEST asymmetry curves for Glutamate and GABA at pH 7.2, with vertical grey lines depicting the 
acquisition frequencies necessary for orCEST calculation and blue and red horizontal lines displaying 
frequencies where ωa = ωb for Glutamate and GABA, respectively. (D) Comparison between 
Conventional CEST and orCEST Glutamate (10 mM) and GABA (2 mM) at pH 7.2, showing increased 
specificity in orCEST. 
 
Fig. 2 Brain Metabolite contamination in CEST/orCEST at 16.4T (A) Raw data acquired for 
characterisation of possible metabolic contamination in orCEST. Brain metabolites at their 
physiological concentrations, Creatine (Cr, 4 mM), myoinositol (MI, 5 mM), N-acetyle aspartate (NAA, 
8 mM), glutamine (Gln, 3 mM), Glu (10 mM) and GABA (2 mM).  Image displays an acquisition without 
any frequency selective saturation pulse, showing no discernible difference between metabolites. (B) 
CEST asymmetry profiles of the aforementioned metabolites showing significant overlap between 
them. (C)(E) Conventional CEST and orCEST maps for Glutamate and GABA, respectively, showing 
improved specificity in both cases, with greatly reduced contamination from unwanted sources. 
(D)(F) Comparison between Conventional CEST and orCEST showing the massive reduction in 
unwanted contribution from other brain metabolites while Glutamate and GABA, respectively, 
maintain their CEST contrast after their respective orCEST subtraction. 
 
Fig. 3 Glutamate and GABA CEST/orCEST pH dependency at 16.4T (A) Raw data acquired for 
characterisation of orCEST, Glutamate (10 mM) and GABA (2 mM) at pH 5.5 and 7.2.  In the 
acquisition without any frequency selective saturation pulse, no discernible difference between 
Glutamate and GABA can be observed at any given pH (B) CEST asymmetry profiles of both Glutamate 
and GABA, at pH 5.5 and 7.2, showing a clear overlap of the two metabolites. (C)(E) Conventional 
CEST and orCEST maps for Glutamate and GABA, respectively, showing improved specificity in both 
cases, with greatly reduced contamination from unwanted sources. (D)(F) Comparison between 
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Conventional CEST and orCEST showing improved specificity with pH. Bright red/blue represents pH 
7.2, while pale red/blue represents pH 5.5, for Glutamate and GABA, respectively. 
 
Fig 4. Raw CEST data and orCEST maps of control rat brains at 9.4T (A) Single animal raw data 
(masked) showing the effects of three different saturation frequencies (0, -3, and +3 p.p.m. from left 
to right), illustrating the effects of direct saturation and asymmetry in saturation effects. SNR ~25 
with saturation at +3 p.p.m.  (B,C) orCEST contrast for Glutamate and GABA in the rat brain, acquired 
across an axial plane at bregma 0.7/-0.9 /-1.46mm. 
 
Fig 5. orCEST variations upon water deprivation in rats at 9.4T (A) Analysis on the average of all 
structures shows a significant downwards trend in both Glutamate and GABA between Control, 24H 
and 36H groups. This is the case for most brain structures. (B,C,D) Specific structures, such as the 
Hypothalamus (bregma -1,46mm), Corpus Callosum (bregma -0.9mm) and Caudate Putamen 
(bregma -0.9mm), exhibit a different behaviour upon water deprivation.  
 
